MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1086/595565

Медицинская библиотека · The Journal of infectious diseases · 2009

Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.

Paran Nir, Suezer Yasemin, Lustig Shlomo, Israely Tomer, Schwantes Astrid, Melamed Sharon, Katz Lior, Preuss Thomas, Hanschmann Kay-Martin, Kalinke Ulrich, Erez Noam, Levin Reuven, Velan Baruch, Löwer Johannes, Shafferman Avigdor, Sutter Gerd

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Decades after the cessation of smallpox vaccination, the potential of the deliberate release of pathogenic orthopoxviruses has forced a reconsideration of using these extremely efficient human vaccines. Scenarios of sudden biothreats have prompted demand for rapidly protective vaccination. However, the feasibility of short-term vaccination (i.e., vaccination shortly before exposure) with vaccinia virus (VACV) is uncertain.

METHODS

We tested the rapid protective capacity of vaccines based on VACV strain Lister (VACV-Lister) and on modified VACV Ankara (MVA) in different mouse models, comparing lethal infections with VACV strain Western Reserve (VACV-WR) or ectromelia virus (ECTV).

RESULTS

In contrast to VACV-WR challenge, we found extended incubation periods after ECTV challenge, allowing successful therapeutic immunization with VACV-Lister and MVA when applied 2-3 days after exposure. Rapid protection from respiratory tract ECTV infection was significantly affected by vaccine dose and was associated with occurrence of poxvirus-specific antibodies. Vaccinations in type I interferon receptor-deficient mice were protective, whereas recombination activating gene 1-deficient mice lacking mature T and B cells failed to mount immunity after short-term vaccination, confirming an essential role of adaptive immune responses.

CONCLUSIONS

ECTV infection in mice models the course of human smallpox. Our data provide evidence to substantiate historical data on the usefulness of postexposure vaccination with conventional VACV and the new candidate MVA to protect against fatal orthopoxvirus infections.

Для цитирования: Paran Nir, Suezer Yasemin, Lustig Shlomo, Israely Tomer, Schwantes Astrid, Melamed Sharon, Katz Lior, Preuss Thomas, Hanschmann Kay-Martin, Kalinke Ulrich, Erez Noam, Levin Reuven, Velan Baruch, Löwer Johannes, Shafferman Avigdor, Sutter Gerd. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.. The Journal of infectious diseases. 2009. DOI: 10.1086/595565.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.